Nigro G, Politano L, Passamano L, Palladino A, De Luca F, Nigro Ge, Comi L I
Department of Experimental Medicine, Cardiomyology and Medical Genetics Service, Second University of Naples, Italy.
Acta Myol. 2006 Dec;25(3):119-23.
The authors have been treating heart involvement in muscle dystrophy since 1978. However, this study aimed to define recent therapeutic protocols, evaluating the results of cardiac treatment, performed between 1st February 2004 and 31st July, 2006. In this period, 100 Becker, 136 Duchenne, 44 Limb-girdle and 116 Steinert patients were treated. In that same period, a large group of MD patients refusing cardiac therapy have also been followed. All patients had previously been classified in the appropriate stage of cardiomyopathy and examined at least twice every year and even every week if presenting heart failure. The results show the usefulness of the recent protocols of treatment of cardiac involvement in muscle dystrophy patients.